Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhaofei Liu

Showing results (61-70 of 123) with videos related to

Pageof 13
Sort By:
Journal of Nanobiotechnology|June 11, 2021
Metabolic radiolabeling and in vivo PET imaging of cytotoxic T lymphocytes to guide combination adoptive cell transfer cancer therapyDehua Lu, Yanpu Wang, Ting Zhang, et al.
Bioconjugate Chemistry|May 22, 2008
99mTc-labeled bombesin(7-14)NH2 with favorable properties for SPECT imaging of colon cancerJiyun Shi, Bing Jia, Zhaofei Liu, et al.
Oncotarget|December 30, 2016
Radiolabeled novel mAb 4G1 for immunoSPECT imaging of EGFRvIII expression in preclinical glioblastoma xenograftsXujie Liu, Chengyan Dong, Jiyun Shi, et al.
Cancer Research|March 26, 2009
Noninvasive de novo imaging of human embryonic stem cell-derived teratoma formationFeng Cao, Zibo Li, Andrew Lee, et al.
Nature Communications|November 30, 2018
Synergistic enzymatic and bioorthogonal reactions for selective prodrug activation in living systemsQingxin Yao, Feng Lin, Xinyuan Fan, et al.
Molecular Pharmaceutics|August 27, 2014
PET imaging of neovascularization with (68)Ga-3PRGD2 for assessing tumor early response to Endostar antiangiogenic therapyJiyun Shi, Zhongxia Jin, Xujie Liu, et al.
Molecular Imaging|June 14, 2013
Technetium 99m-labeled VQ peptide: a new imaging agent for the early detection of tumors or premalignanciesJiyun Shi, Liyang Cui, Bing Jia, et al.
Journal for Immunotherapy of Cancer|November 18, 2020
Nuclear imaging-guided PD-L1 blockade therapy increases effectiveness of cancer immunotherapyHannan Gao, Yue Wu, Jiyun Shi, et al.
Theranostics|February 8, 2014
Anti-tumor effect of integrin targeted (177)Lu-3PRGD2 and combined therapy with EndostarJiyun Shi, Di Fan, Chengyan Dong, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2014
Longitudinal monitoring of tumor antiangiogenic therapy with near-infrared fluorophore-labeled agents targeted to integrin αvβ3 and vascular endothelial growth factorXianlei Sun, Teng Ma, Hao Liu, et al.
Pageof 13

Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
Journal of Nanobiotechnology|June 11, 2021
Metabolic radiolabeling and in vivo PET imaging of cytotoxic T lymphocytes to guide combination adoptive cell transfer cancer therapyDehua Lu, Yanpu Wang, Ting Zhang, et al.
Bioconjugate Chemistry|May 22, 2008
99mTc-labeled bombesin(7-14)NH2 with favorable properties for SPECT imaging of colon cancerJiyun Shi, Bing Jia, Zhaofei Liu, et al.
Oncotarget|December 30, 2016
Radiolabeled novel mAb 4G1 for immunoSPECT imaging of EGFRvIII expression in preclinical glioblastoma xenograftsXujie Liu, Chengyan Dong, Jiyun Shi, et al.
Cancer Research|March 26, 2009
Noninvasive de novo imaging of human embryonic stem cell-derived teratoma formationFeng Cao, Zibo Li, Andrew Lee, et al.
Nature Communications|November 30, 2018
Synergistic enzymatic and bioorthogonal reactions for selective prodrug activation in living systemsQingxin Yao, Feng Lin, Xinyuan Fan, et al.
Molecular Pharmaceutics|August 27, 2014
PET imaging of neovascularization with (68)Ga-3PRGD2 for assessing tumor early response to Endostar antiangiogenic therapyJiyun Shi, Zhongxia Jin, Xujie Liu, et al.
Molecular Imaging|June 14, 2013
Technetium 99m-labeled VQ peptide: a new imaging agent for the early detection of tumors or premalignanciesJiyun Shi, Liyang Cui, Bing Jia, et al.
Journal for Immunotherapy of Cancer|November 18, 2020
Nuclear imaging-guided PD-L1 blockade therapy increases effectiveness of cancer immunotherapyHannan Gao, Yue Wu, Jiyun Shi, et al.
Theranostics|February 8, 2014
Anti-tumor effect of integrin targeted (177)Lu-3PRGD2 and combined therapy with EndostarJiyun Shi, Di Fan, Chengyan Dong, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2014
Longitudinal monitoring of tumor antiangiogenic therapy with near-infrared fluorophore-labeled agents targeted to integrin αvβ3 and vascular endothelial growth factorXianlei Sun, Teng Ma, Hao Liu, et al.
Pageof 13